Lam Research price target raised to $160 from $150 at Needham on strong China sales

Published 23/10/2025, 13:04
Lam Research price target raised to $160 from $150 at Needham on strong China sales

Investing.com - Needham raised its price target on Lam Research (NASDAQ:LRCX) to $160.00 from $150.00 on Thursday, maintaining a Buy rating following the semiconductor equipment maker’s quarterly results. According to InvestingPro data, Lam Research, currently valued at $178 billion, has demonstrated impressive momentum with a 96% return over the past year.

The semiconductor equipment manufacturer reported a slight revenue beat for the third quarter of 2025, while providing fourth-quarter guidance that exceeded Wall Street expectations.

China sales were a significant driver of Lam’s performance, increasing 25% quarter-over-quarter and accounting for 43% of total revenue in the third quarter, which boosted foundry/logic revenue and gross margin strength.

Looking ahead to the fourth quarter, Lam expects China revenue to decline partly due to the new U.S. government "50% rule," which is projected to impact sales by $200 million in the fourth quarter and $600 million in calendar year 2026.

Despite the anticipated China slowdown in 2026, Needham remains optimistic about Lam’s prospects, citing management’s outlook for strong performance in other regions due to robust wafer fabrication equipment demand across all segments, including continued NAND upgrades.

In other recent news, Lam Research reported its fiscal first-quarter earnings for 2026, surpassing Wall Street expectations with a diluted earnings per share of $1.26, compared to the forecast of $1.22. The company’s revenue also exceeded predictions, reaching $5.32 billion against an anticipated $5.22 billion. Despite these positive results, analysts have varied expectations for the stock’s future. UBS raised its price target for Lam Research to $165 from $155, citing stronger-than-expected guidance and projecting earnings per share of approximately $5.25-5.50 for 2026. Stifel also increased its price target to $160 from $135, following the company’s fiscal first-quarter results, which exceeded both Stifel’s and consensus expectations. Mizuho raised its price target to $170 from $162, noting the company’s September quarter results and December quarter guidance of $5.20 billion, which surpassed the $4.8 billion consensus expectation. Meanwhile, Goldman Sachs maintained its Buy rating and $160 price target, acknowledging strong earnings but suggesting the stock may remain range-bound. These developments reflect the mixed reactions and varied expectations among analysts regarding Lam Research’s financial performance and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.